You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Endocrine Neoplasia Type 2b

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

Completed
Has Results
  • Medullary Thyroid Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 1, 2020

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

    Recruiting
    • Neuroendocrine Tumor of Pancreas
    • Multiple Endocrine Neoplasia Type 1
    • High-dose-high precision MR-guided radiotherapy
    • Utrecht, Netherlands
      UMC Utrecht
    May 29, 2022

    Natural History Study of Parathyroid Disorders

    Recruiting
    • Parathyroid Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 19, 2023

      Study and Monitoring of Multiple Endocrine Neoplasia Type 1

      Recruiting
      • MEN1
      • Questionnaires
      • Dijon, France
        CHU Dijon Bourgogne
      Jan 4, 2022

      Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

      Recruiting
      • Multiple Endocrine Neoplasia Type 1
      • Pancreatic Neuroendocrine Tumor
      • EUS-guided fine-needle injection
      • Nanning, Guangxi, China
        First Affiliated Hospital of Guangxi Medical University
      Sep 24, 2022

      Genetic Factors and Pheochromocytomas in Neoplasia Type 2

      Recruiting
      • Neoplasia
      • Pheochromocytoma
        • Marseille, France
          APHM - Hôpital de la Conception
        Jan 30, 2022

        MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

        Not yet recruiting
        • MEN1 Gene Mutation
        • Leflunomide 20 mg
        • Basel, Switzerland
          Unispital Basel
        Nov 1, 2022

        Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

        Recruiting
        • Advanced Carcinoid Tumor
        • +4 more
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 22, 2022

        Familial Investigations of Childhood Cancer Predisposition

        Recruiting
        • Acute Leukemia
        • +45 more
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          May 11, 2022

          Routine Transcervical Thymectomy in MEN-1 Patients

          Completed
          • Multiple Endocrine Neoplasia Type 1 (MEN-1)
          • Thymic Carcinoid
          • Routine thymectomy, which has been performed
          • Singapore, Singapore
            National University Hospital
          Sep 25, 2021

          Adrenal and Other Endocrine Tumors in Patients With Sudden Death

          Recruiting
          • Primary Aldosteronism
          • +3 more
          • Adrenal aldosterone synthase (CYP11B2) staining
          • +2 more
          • Helsinki, Finland
            Endocrinology, Helsinki University Hospital and University of He
          Jul 8, 2022

          Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

          Completed
          Has Results
          • Gastrin-Producing Neuroendocrine Tumor
          • +10 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Boston, Massachusetts
          • +2 more
          Mar 25, 2020

          A Retrospective Study for Multiple Endocrine Neoplasia

          Recruiting
          • Multiple Endocrine Neoplasia
          • no intervention
          • Taipei, Taiwan
            National Taiwan University Hospital
          Apr 2, 2023

          Long QT Syndrome Trial in West Bend (LQT-1213, Placebo, Dofetilide 250 µg Cap)

          Active, not recruiting
          • Long QT Syndrome
          • West Bend, Wisconsin
            Spaulding Clinical Research, LLC
          Jun 15, 2023

          Kidney Diseases, Diabetic Nephropathies, Diabetes Complications Trial in San Antonio (GFB-024, Placebo)

          Completed
          • Kidney Diseases
          • +4 more
          • San Antonio, Texas
            Worldwide Clinical Trials
          Mar 24, 2022

          Diabetes, Type 2 Trial in Neuss (LY3532226, Placebo, Dulaglutide)

          Recruiting
          • Diabetes Mellitus, Type 2
          • Neuss, Germany
            Profil Institut für Stoffwechselforschung
          Jun 30, 2022

          Overweight or Obesity, CKD, Type 2 Diabetes Trial in Worldwide (LY3437943, Placebo)

          Not yet recruiting
          • Overweight or Obesity
          • +2 more
          • Canoga Park, California
          • +19 more
          Jun 30, 2023

          Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

          Active, not recruiting
          • Recurrent Plasma Cell Myeloma
          • Refractory Plasma Cell Myeloma
          • Los Angeles, California
            USC / Norris Comprehensive Cancer Center
          Aug 5, 2022

          Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed

          Terminated
          • Meningioma
          • +5 more
          • Computed Tomography
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Feb 11, 2021

          Called FINE-REAL to Learn More About Use of Drug Finerenone

          Recruiting
          • Chronic Kidney Disease
          • Type 2 Diabetes Mellitus
          • Kerendia (Finerenone, BAY94-8862)
          • Huntsville, Alabama
          • +53 more
          Aug 15, 2022

          Spasticity, Cerebrovascular Accident, Multiple Sclerosis Trial in Czechia, United States (Phase 2; Low Dose MYOBLOC, Phase 2;

          Recruiting
          • Spasticity
          • +5 more
          • Phase 2; Low Dose MYOBLOC
          • +4 more
          • Downey, California
          • +8 more
          Mar 4, 2022

          Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)

          Completed
          Has Results
          • Hyperparathyroidism
          • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          May 12, 2022

          Type 1 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

          Completed
          Has Results
          • Type 1 Diabetes Mellitus
          • Concord, California
          • +53 more
          Sep 29, 2022

          Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (Bortezomib, Dexamethasone, Pelareorep)

          Not yet recruiting
          • Recurrent Plasma Cell Myeloma
          • Refractory Plasma Cell Myeloma
          • Los Angeles, California
          • +1 more
          Aug 19, 2022